Terpstra, Lotte C.
Altenburg, Josje
Bronsveld, Inez
de Kruif, Martijn D.
Berk, Yvonne
Snijders, Dominic
Rozemeijer, Wouter
Heijerman, Harry G. M.
Boersma, Wim G.
Funding for this research was provided by:
unrestricted grant from TEVA pharmaceutics
Article History
Received: 24 May 2022
Accepted: 6 November 2022
First Online: 3 December 2022
Declarations
:
: Approval of Independent Ethics Committees and Institutional Review Boards was obtained from all the participating centers. Clinical trials.gov number of the BATTLE study: NCT02657473. EudraCT number of the BATTLE study: 2016-000166-35. Written informed consent for participation and publication of our results was obtained from all the participants at the screenings visit.
: Not applicable.
: WGB received an unrestricted grant from TEVA pharmaceutics and TIS was supplied by TEVA pharmaceutics. The other authors have no competing interest.